Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OBINUTUZUMAB vs UBLITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OBINUTUZUMAB vs UBLITUXIMAB: Safety Overview

Metric OBINUTUZUMAB UBLITUXIMAB
Total FAERS Reports 14,189 1,582
Deaths Reported 1,919 27
Death Rate 13.5% 1.7%
Hospitalizations 5,419 213
Average Patient Age 63.8 yrs 49.7 yrs
% Female Patients 41.7% 73.4%
Manufacturer Genentech, Inc. TG Therapeutics, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A